ADAMIS PHARMACEUTICALS CORP (ADMP)       0.1853  -0.01 (-3.74%)

0.1853  -0.01 (-3.74%)

US00547W2089 - Common Stock - After market: 0.185 0 (-0.16%)

EPS Estimates (USD)

Recent Earnings VS Estimates
Period Reported Estimate Difference Surprise Q3 2022 -0.03 -0.03 0.001.96% Q2 2022 -0.06 -0.04 -0.02-68.07% Q1 2022 -0.07 -0.03 -0.04-128.76% Q4 2021 -0.06 -0.05 -0.01-30.72% Q3 2021 -0.11 -0.04 -0.07-169.61% Q2 2021 -0.06 -0.06 0.00-6.95% Q1 2021 -0.12 -0.06 -0.06-96.08% Q4 2020 -0.24 -0.06 -0.18-292.16%
Future EPS Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 -0.15 -0.35 56.29%Q4 2022 -0.01 -0.06 83.00%FY 2023 -0.06 -0.15 60.00%FY 2024 -0.03 -0.06 50.00%FY 2025 -0.05 -0.03 -51.96%FY 2026 -0.07 -0.05 -55.00%

Revenue Estimates (USD)

Recent Revenue VS Estimates
Period Reported Estimate Difference Surprise Q3 2022 1.506M 1.632M -126.32K-7.74% Q2 2022 1.1M 1.038M 61.71K5.95% Q1 2022 1.155M 3.831M -2.677M-69.86% Q4 2021 2.209M 2.874M -665.32K-23.15% Q3 2021 759.96K 1.42M -659.88K-46.48% Q2 2021 1.275M 3.154M -1.879M-59.56% Q1 2021 1.393M 3.535M -2.142M-60.59% Q4 2020 3.64M 5.821M -2.181M-37.47%
Future Revenue Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 6.426M 2.209M 190.94%Q4 2022 3.162M 2.209M 43.16%FY 2023 11.628M 6.426M 80.95%FY 2024 15.198M 11.628M 30.70%FY 2025 21.139M 15.198M 39.09%FY 2026 25.564M 21.139M 20.93%